PDCD1 and neoplasm: Although PD-1/CD279 has been reported as an immunosuppressive checkpoint, which is expressed on activated T cells and hijacked by tumors to escape immune surveillance and induce immune tolerance [46,47,48], it could be more accurately defined as a marker for tumor-reactive T cells to recognize tumor cells [49].